Want to see SGMOQ full AI Analyst Report?
Sangamo Therapeutics (SGMOQ) Financial Statements
Sangamo Therapeutics Financial Overview
Sangamo Therapeutics's market cap is currently $48.06M. The company's EPS TTM is $-0.38; its P/E ratio is -0.20; Sangamo Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 39.55M | $ 57.80M | $ 176.23M | $ 111.30M | $ 110.70M |
| Gross Profit | $ 31.95M | $ 57.80M | $ 176.23M | $ 99.19M | $ 110.70M |
| Operating Income | $ -108.00M | $ -103.97M | $ -274.00M | $ -201.28M | $ -183.34M |
| EBITDA | $ -115.90M | $ -89.09M | $ -96.80M | $ -179.74M | $ -160.35M |
| Net Income | $ -122.93M | $ -97.94M | $ -257.83M | $ -192.28M | $ -178.29M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 20.95M | $ 41.92M | $ 81.00M | $ 277.63M | $ 376.55M |
| Total Assets | $ 59.74M | $ 101.64M | $ 165.32M | $ 562.51M | $ 721.92M |
| Total Debt | $ 26.80M | $ 30.57M | $ 38.10M | $ 43.11M | $ 48.08M |
| Net Debt | $ 5.85M | $ -11.35M | $ -7.10M | $ -57.34M | $ -130.79M |
| Total Liabilities | $ 74.01M | $ 78.86M | $ 82.43M | $ 267.55M | $ 346.58M |
| Stockholders' Equity | $ -14.27M | $ 22.77M | $ 82.89M | $ 294.96M | $ 375.34M |
| Cash Flow | |||||
| Free Cash Flow | $ -97.31M | $ -67.41M | $ -246.00M | $ -243.80M | $ -256.53M |
| Operating Cash Flow | $ -97.21M | $ -67.14M | $ -224.84M | $ -223.63M | $ -233.25M |
| Investing Cash Flow | $ -102.00K | $ 37.52M | $ 153.53M | $ 59.28M | $ 248.20M |
| Financing Cash Flow | $ 70.75M | $ 28.38M | $ 14.59M | $ 84.66M | $ 32.86M |
Currency in USD